Gerrit Dispersyn
Overview
Gerrit Dispersyn received an average of $511K in total compensation, including $291K in salary, at RXi Pharmaceuticals from 2017 to 2022.
2022RXi PharmaceuticalsFormer President and Chief Executive Officer
2021RXi PharmaceuticalsFormer President and Chief Executive Officer
2019RXi PharmaceuticalsPresident and Chief Executive Officer
2018RXi PharmaceuticalsPresident and Chief Executive Officer
2017RXi PharmaceuticalsChief Development Officer
Source: SEC filings on June 9, 2023, August 28, 2020, August 30, 2019, and April 26, 2018.
Related executives
We found six more executives who work or worked at RXi Pharmaceuticals.
Robert Bitterman
RXi Pharmaceuticals
Chief Executive Officer
Geert Cauwenbergh
RXi Pharmaceuticals
Former interim Principal Executive and Financial Officer
John Barrett
RXi Pharmaceuticals
Former Chief Development Officer
Alexey Eliseev
RXi Pharmaceuticals
Former Chief Business Officer
Pamela Pavco
RXi Pharmaceuticals
Former Chief Development Officer
Anastasia Khvorova
RXi Pharmaceuticals